Physician profile
Elmer E Croushore
NPI 1740243518
$5,681.12
in general payments reported to CMS, 2019-2025
34 companies · $633 in 2025
The $633 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,395 · 2020: $656 · 2021: $742 · 2022: $521 · 2023: $909 · 2024: $824 · 2025: $633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,366.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,909.87 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Iliac Branch Endoprosthesis |
| Silk Road Medical, INC. | $554.32 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Bard Peripheral Vascular, INC. | $360.65 | 2020-2023 | Venovo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $254.32 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $253.76 | 2019-2024 | Xarelto |
| Pfizer INC. | $248.86 | 2019-2024 | |
| Cook Medical LLC | $225.13 | 2020-2025 | Zilver Ptx |
| Merck Sharp & Dohme LLC | $224.87 | 2022-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $219.71 | 2022-2025 | |
| Lexicon Pharmaceuticals, INC. | $177.13 | 2023-2024 | Inpefa |
| Amgen INC. | $174.18 | 2019-2024 | Repatha |
| Sanofi-Aventis U.S. LLC | $137.54 | 2019 | |
| Penumbra, INC. | $102.95 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $84.48 | 2019-2023 | Lifevest |
| Kiniksa Pharmaceuticals, LTD. | $81.96 | 2022-2023 | Arcalyst |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $78.12 | 2024 | Watchman Flx |
| Bayer Healthcare Pharmaceuticals INC. | $67.85 | 2023-2025 | |
| Cvrx, INC. | $66.09 | 2025 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $65.73 | 2019-2025 | |
| Philips North America LLC | $64.23 | 2021-2024 | (Ck6) Holter |
| Kiniksa Pharmaceuticals International, Plc | $54.22 | 2024 | Arcalyst |
| Neuros Medical, INC. | $41.94 | 2025 | Altius |
| Amarin Pharma, INC. | $32.91 | 2019 | |
| Lemaitre Vascular, INC. | $26.62 | 2023 | Pruitt F3 Carotid Shunt, Restoreflow |
| Cardiva Medical, INC. | $24.97 | 2025 | Optowire |
| Getinge USA Sales, LLC | $20.52 | 2024 | Vasoview Hemopro 2 |
| Idorsia Pharmaceuticals US INC | $19.52 | 2025 | Tryvio |
| Tactile Systems Technology INC | $18.17 | 2024 | Entre Plus, Flexitouch Plus |
| Angiodynamics, INC. | $17.48 | 2024 | Auryon Laser System 100-120 Vac |
| Novo Nordisk INC | $16.52 | 2023 | Rybelsus, Ozempic |
| Inspire Medical Systems, INC. | $14.34 | 2023 | Inspire |
| Organogenesis INC. | $14.23 | 2023 | Puraply |
| Smith+Nephew, INC. | $14.06 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elmer Croushore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.